Skip to content
Peptide research

Svetinorm

Also known as Liver Bioregulator
Category
Bioregulators
Administration routes
Oral
Regulatory status
Not FDA-approved

What it is

Svetinorm is a liver-derived bioregulator peptide marketed to aid liver regeneration in hepatitis, chemo recovery, and general liver strain. Benefits remain unproven, despite an internal report describing human outcomes. It is not a substitute for medical treatment, and mild allergy to the material is possible. It is not FDA-approved; it is sold internationally as a dietary supplement, and unregulated products sold online vary in quality.

Read Full record

Studied uses & evidence

Studied uses(4)

  • Hepatoprotective effects in chronic hepatitis

    Speculative

    An internal human report studied Svetinorm; benefit remains uncertain.

  • Improved liver function markers (bilirubin, ALT reduction)

    Speculative

    An internal human report includes bilirubin and ALT measurements; efficacy remains unconfirmed.

  • Post-chemotherapy liver recovery support

    Speculative

    An internal report includes 13 post-chemotherapy patients; benefit remains uncertain.

Evidence limits

Evidence Level
Limited Evidence

Svetinorm has a formal clinical study from the Khavinson Institute testing 47 patients against 38 controls, which is among the better-documented bioregulator studies. Results showed hepatoprotective effects in chronic hepatitis and post-chemotherapy patients with improvements in both subjective symptoms and biochemical markers. However, the study was open-label, conducted at a single center, and has not been replicated outside Russia.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(2)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Allergic reaction to bovine liver-derived peptides

    Low
  • Not a substitute for medical liver treatment

    High
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.